论有效性-多样性权衡中对多样性的低估

IF 3.5 2区 生物学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY
J. Olenick, Ajay V. Somaraju
{"title":"论有效性-多样性权衡中对多样性的低估","authors":"J. Olenick, Ajay V. Somaraju","doi":"10.1017/iop.2023.29","DOIUrl":null,"url":null,"abstract":"Sackett et al. (2023) provide a useful more practice-oriented discussion of Sackett et al. (2022) report that reexamined meta-analytic corrections for a wide variety of selection tools, across common content and process domains. We expand on their discussion of implications regarding the new validity estimates for the classic validity – diversity tradeoff by arguing that the benefits of diversity are still underestimated when assessing this tradeoff. To be fair, this issue is not limited to Sackett et al. ’ s efforts but rather represents a shortcoming of the field at large. Regardless, these limitations mean that if diversity benefits were better understood by the field and properly accounted for in tradeoff estimates, even greater reductions in the usefulness of predictors with high group mean differences would likely be observed. We make three key points. First, we argue that the benefits of group diversity are not included in selection decisions, leading to underestimations of diversity benefits. Second, we elaborate on the central role of interdependence as a condition that maximizes the importance of diversity. Finally, we connect these issues to the long-term implications of assessment decisions containing adverse impact.","PeriodicalId":11,"journal":{"name":"ACS Chemical Biology","volume":null,"pages":null},"PeriodicalIF":3.5000,"publicationDate":"2023-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"On the undervaluing of diversity in the validity–diversity tradeoff consideration\",\"authors\":\"J. Olenick, Ajay V. Somaraju\",\"doi\":\"10.1017/iop.2023.29\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Sackett et al. (2023) provide a useful more practice-oriented discussion of Sackett et al. (2022) report that reexamined meta-analytic corrections for a wide variety of selection tools, across common content and process domains. We expand on their discussion of implications regarding the new validity estimates for the classic validity – diversity tradeoff by arguing that the benefits of diversity are still underestimated when assessing this tradeoff. To be fair, this issue is not limited to Sackett et al. ’ s efforts but rather represents a shortcoming of the field at large. Regardless, these limitations mean that if diversity benefits were better understood by the field and properly accounted for in tradeoff estimates, even greater reductions in the usefulness of predictors with high group mean differences would likely be observed. We make three key points. First, we argue that the benefits of group diversity are not included in selection decisions, leading to underestimations of diversity benefits. Second, we elaborate on the central role of interdependence as a condition that maximizes the importance of diversity. Finally, we connect these issues to the long-term implications of assessment decisions containing adverse impact.\",\"PeriodicalId\":11,\"journal\":{\"name\":\"ACS Chemical Biology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":3.5000,\"publicationDate\":\"2023-08-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ACS Chemical Biology\",\"FirstCategoryId\":\"102\",\"ListUrlMain\":\"https://doi.org/10.1017/iop.2023.29\",\"RegionNum\":2,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Chemical Biology","FirstCategoryId":"102","ListUrlMain":"https://doi.org/10.1017/iop.2023.29","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 1

摘要

Sackett等人(2023)对Sackett等人(2022)的报告进行了有益的、更以实践为导向的讨论,该报告重新检查了跨共同内容和过程域的各种选择工具的元分析更正。我们扩展了他们对经典效度-多样性权衡的新效度估计的影响的讨论,认为在评估这种权衡时,多样性的好处仍然被低估了。公平地说,这个问题并不局限于Sackett等人的努力,而是代表了整个领域的一个缺点。无论如何,这些限制意味着,如果该领域更好地理解多样性的好处,并在权衡估计中适当地考虑到这一点,那么可能会观察到具有高组平均差异的预测因子的有用性会进一步降低。我们提出了三个关键点。首先,我们认为群体多样性的好处没有包括在选择决策中,导致低估多样性的好处。第二,我们详细阐述了相互依存作为使多样性的重要性最大化的一个条件的中心作用。最后,我们将这些问题与包含不利影响的评估决策的长期影响联系起来。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
On the undervaluing of diversity in the validity–diversity tradeoff consideration
Sackett et al. (2023) provide a useful more practice-oriented discussion of Sackett et al. (2022) report that reexamined meta-analytic corrections for a wide variety of selection tools, across common content and process domains. We expand on their discussion of implications regarding the new validity estimates for the classic validity – diversity tradeoff by arguing that the benefits of diversity are still underestimated when assessing this tradeoff. To be fair, this issue is not limited to Sackett et al. ’ s efforts but rather represents a shortcoming of the field at large. Regardless, these limitations mean that if diversity benefits were better understood by the field and properly accounted for in tradeoff estimates, even greater reductions in the usefulness of predictors with high group mean differences would likely be observed. We make three key points. First, we argue that the benefits of group diversity are not included in selection decisions, leading to underestimations of diversity benefits. Second, we elaborate on the central role of interdependence as a condition that maximizes the importance of diversity. Finally, we connect these issues to the long-term implications of assessment decisions containing adverse impact.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
ACS Chemical Biology
ACS Chemical Biology 生物-生化与分子生物学
CiteScore
7.50
自引率
5.00%
发文量
353
审稿时长
3.3 months
期刊介绍: ACS Chemical Biology provides an international forum for the rapid communication of research that broadly embraces the interface between chemistry and biology. The journal also serves as a forum to facilitate the communication between biologists and chemists that will translate into new research opportunities and discoveries. Results will be published in which molecular reasoning has been used to probe questions through in vitro investigations, cell biological methods, or organismic studies. We welcome mechanistic studies on proteins, nucleic acids, sugars, lipids, and nonbiological polymers. The journal serves a large scientific community, exploring cellular function from both chemical and biological perspectives. It is understood that submitted work is based upon original results and has not been published previously.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信